Anti-DIPK1B monoclonal antibody

Pre-made anti-DIPK1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DIPK1B/DIPK1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0826-Ab-1/ GM-Tg-hg-IP0826-Ab-2Anti-Human DIPK1B monoclonal antibodyHuman
GM-Tg-rg-IP0826-Ab-1/ GM-Tg-rg-IP0826-Ab-2Anti-Rat DIPK1B monoclonal antibodyRat
GM-Tg-mg-IP0826-Ab-1/ GM-Tg-mg-IP0826-Ab-2Anti-Mouse DIPK1B monoclonal antibodyMouse
GM-Tg-cynog-IP0826-Ab-1/ GM-Tg-cynog-IP0826-Ab-2Anti-Cynomolgus/ Rhesus macaque DIPK1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0826-Ab-1/ GM-Tg-felg-IP0826-Ab-2Anti-Feline DIPK1B monoclonal antibodyFeline
GM-Tg-cang-IP0826-Ab-1/ GM-Tg-cang-IP0826-Ab-2Anti-Canine DIPK1B monoclonal antibodyCanine
GM-Tg-bovg-IP0826-Ab-1/ GM-Tg-bovg-IP0826-Ab-2Anti-Bovine DIPK1B monoclonal antibodyBovine
GM-Tg-equg-IP0826-Ab-1/ GM-Tg-equg-IP0826-Ab-2Anti-Equine DIPK1B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0826-Ab-1/ GM-Tg-hg-IP0826-Ab-2; GM-Tg-rg-IP0826-Ab-1/ GM-Tg-rg-IP0826-Ab-2;
GM-Tg-mg-IP0826-Ab-1/ GM-Tg-mg-IP0826-Ab-2; GM-Tg-cynog-IP0826-Ab-1/ GM-Tg-cynog-IP0826-Ab-2;
GM-Tg-felg-IP0826-Ab-1/ GM-Tg-felg-IP0826-Ab-2; GM-Tg-cang-IP0826-Ab-1/ GM-Tg-cang-IP0826-Ab-2;
GM-Tg-bovg-IP0826-Ab-1/ GM-Tg-bovg-IP0826-Ab-2; GM-Tg-equg-IP0826-Ab-1/ GM-Tg-equg-IP0826-Ab-2
Products NameAnti-DIPK1B monoclonal antibody
Formatmab
Target NameDIPK1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DIPK1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0826-Ag-1Recombinant multi-species DIK1B/ DIPK1B/ C9orf136 protein


    Target information

    Target IDGM-IP0826
    Target NameDIPK1B
    Gene ID138311,56279,362090,709652,491248,101094888,539229,100068815
    Gene Symbol and SynonymsB230317C12Rik,C9orf136,DIPK1B,FAM69B,PIP49,pp6977,RGD1308600
    Uniprot AccessionQ5VUD6,Q5FVL3
    Uniprot Entry NameDIK1B_HUMAN,DIK1B_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165716
    Target ClassificationN/A

    The target: DIPK1B, gene name: DIPK1B, also named as C9orf136, FAM69B, pp6977. This gene encodes a member of the FAM69 family of cysteine-rich type II transmembrane proteins. These proteins localize to the endoplasmic reticulum but their specific functions are unknown. [provided by RefSeq, Nov 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.